Generic Name: fluocinolone acetonide
Brand Name: Iluvien
Manufacturer: Knight Therapeutics Inc.
Therapeutic Area: Diabetic macular edema (DME)
Indications: Diabetic macular edema (DME)
Submission Type: Initial
Project Status: Withdrawn
Biosimilar: No
Fee Schedule: Schedule A
Key Milestones2 | |
|---|---|
| Call for patient input posted | November 22, 2017 |
| Patient group input closed | January 18, 2018 |
| Clarification: - No patient input submission received | |
| Submission received | December 21, 2017 |
| Submission accepted for review | January 12, 2018 |
| Review initiated | January 15, 2018 |
| Clarification: - Voluntarily withdrawn by the manufacturer on 2018-Mar-23 | |